Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Enzastaurin in Vascular Ehlers-Danlos Syndrome.
Condition: Vascular Ehlers-Danlos Syndrome Interventions: Drug: Enzastaurin; Drug: Placebo Sponsors: Aytu BioPharma, Inc.; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Ehlers-Danlos Syndrome | Research